QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan
QT Imaging Holdings (NASDAQ:QTI), a medical device company specializing in innovative body imaging systems, has announced its participation in the IEEE International Ultrasonics Symposium (IUS) in Taipei, Taiwan, from September 22-26, 2024. Dr. James Wiskin will represent QTI in the Medical Imaging subsection, presenting on a novel application of machine learning for image 'cleaning' or artifact removal. This technique preserves diagnostic and quantitative information for accurate diagnoses, applicable to breast images as well as high-resolution orthopedic and pediatric 3D images produced by QTI's technology.
QT Imaging Holdings (NASDAQ:QTI), un'azienda di dispositivi medici specializzata in sistemi innovativi di imaging del corpo, ha annunciato la sua partecipazione al Simposio Internazionale di Ultrasonografia IEEE (IUS) a Taipei, Taiwan, dal 22 al 26 settembre 2024. Il Dr. James Wiskin rappresenterà QTI nella sezione di Imaging Medico, presentando un nuovo utilizzo del machine learning per la 'pulizia' delle immagini o rimozione degli artefatti. Questa tecnica preserva le informazioni diagnostiche e quantitative per diagnosi accurate, applicabile a immagini mammografiche così come a immagini ortopediche e pediatriche 3D ad alta risoluzione prodotte dalla tecnologia di QTI.
QT Imaging Holdings (NASDAQ:QTI), una empresa de dispositivos médicos especializada en sistemas innovadores de imagen corporal, ha anunciado su participación en el Simposio Internacional de Ultrasonido IEEE (IUS) en Taipei, Taiwán, del 22 al 26 de septiembre de 2024. El Dr. James Wiskin representará a QTI en la subsección de Imágenes Médicas, presentando una nueva aplicación de aprendizaje automático para la 'limpieza' de imágenes o eliminación de artefactos. Esta técnica preserva la información diagnóstica y cuantitativa para diagnósticos precisos, aplicable a imágenes de mama así como a imágenes ortopédicas y pediátricas 3D de alta resolución producidas por la tecnología de QTI.
QT Imaging Holdings (NASDAQ:QTI)는 혁신적인 신체 이미징 시스템을 전문으로 하는 의료 기기 회사로, 대만 타이페이에서 2024년 9월 22일부터 26일까지 개최되는 IEEE 국제 초음파 심포지엄 (IUS)에 참가한다고 발표했습니다. 제임스 위스킨 박사가 의료 이미징 부문에서 QTI를 대표하여 기계 학습의 새로운 적용에 대해 '이미지 정리' 또는 아티팩트 제거에 대한 발표를 할 예정입니다. 이 기술은 정확한 진단을 위한 진단 및 정량적 정보를 보존하며, QTI 기술로 생성된 유방 이미지는 물론 고해상도 정형외과 및 소아 3D 이미지에도 적용됩니다.
QT Imaging Holdings (NASDAQ:QTI), une entreprise de dispositifs médicaux spécialisée dans les systèmes d'imagerie corporelle innovants, a annoncé sa participation au Symposium International sur l'Ultrason IEEE (IUS) à Taipei, Taïwan, du 22 au 26 septembre 2024. Le Dr James Wiskin représentera QTI dans la sous-section d'Imagerie Médicale, présentant une nouvelle application de l'apprentissage automatique pour le nettoyage d'images ou la suppression d'artefacts. Cette technique préserve les informations diagnostiques et quantitatives pour des diagnostics précis, applicable à des images mammaires ainsi qu'à des images 3D orthopédiques et pédiatriques haute résolution produites par la technologie de QTI.
Die QT Imaging Holdings (NASDAQ:QTI), ein medizinisches Gerätunternehmen, das sich auf innovative Körperscanning-Systeme spezialisiert hat, hat ihre Teilnahme am IEEE International Ultrasonics Symposium (IUS) in Taipeh, Taiwan, vom 22. bis 26. September 2024, bekannt gegeben. Dr. James Wiskin wird QTI in der Rubrik Medizinische Bildgebung vertreten und über eine neuartige Anwendung von maschinellem Lernen zur 'Bereinigung' von Bildern oder zur Entfernung von Artefakten präsentieren. Diese Technik bewahrt diagnostische und quantitative Informationen für genaue Diagnosen und ist sowohl auf Mammografien als auch auf hochauflösende orthopädische und pädiatrische 3D-Bilder anwendbar, die mit der Technologie von QTI erstellt wurden.
- Participation in a prestigious international symposium enhances company visibility
- Presentation of novel machine learning application demonstrates technological innovation
- Technology applicable to multiple imaging areas (breast, orthopedic, pediatric) indicates versatility
- None.
The presentation focusses on a novel application of machine learning to generate image ‘cleaning’ or removal of artifacts without compromising diagnostic information, while the quantitative information is preserved, for accurate diagnoses. This architecture is applicable to not only breast images, but also the high resolution, quantitative, reproducible orthopedic and pediatric 3D images produced by the QTI imaging technology, today and in the future.
About QT Imaging Holding, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding plans for QT Imaging Holdings, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905846805/en/
For media inquiries, please contact:
Susan Schaffler
Head of Communications
Susan.Schaffler@qtimaging.com
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com
Source: QT Imaging Holding, Inc.
FAQ
When and where is QT Imaging Holdings (QTI) participating in the IEEE International Ultrasonics Symposium?
What will QT Imaging Holdings (QTI) present at the IEEE International Ultrasonics Symposium?
What types of medical imaging does QT Imaging Holdings' (QTI) technology apply to?
